Table 4 DTRPs identified and resolved by pharmacists in a 45-year-old type 2 diabetes and hypertensive SP.
Classification and types of DTRPs | Identified n (%) | Not identified n (%) |
|---|---|---|
Drug therapy is used for an avoidable adverse drug reaction/side effects associated with another medication | ||
Coflin Lintus® possibly for cough associated with lisinopril. | 4 (11.1) | 32 (88.9) |
Adverse drug reaction (A drug interaction causes an undesirable reaction that is not dose-related) | ||
Diclofenac + lisinopril decreases renal functiona | 3 (8.3) | 33 (91.7) |
Dose too high (The dose too high for the patient) | ||
Glibenclamide 10 mg taken twice daily because of duplicate product. | 31 (86.1) | 5 (13.9) |
Action taken to investigate DRP | Action taken n (%) | Action not taken n (%) |
Checked for drug interaction. | 2 (5.6) | 34 (94.4) |
Asked for clarification concerning the medicines. | 32 (88.9) | 4 (11.1) |
Probe the patient further about other symptoms of hypoglycaemia e.g., tremor, increased heart rate | 21 (58.3) | 15 (41.7) |
Recommendations made to resolve the DTRPs | Recommendation made n (%) | Recommendation not made n (%) |
Suggested the stoppage of diclofenac tablets. | 6 (16.7) | 30 (83.3) |
Suggested the discontinuation of one of the glibenclamide brand. | 32 (88.9) | 4 (11.1) |
Suggested the patient see the physician for a possible replacement for lisinopril since the patient experienced episodes of uncomfortable dry cough. | 4 (11.1) | 32 (88.9) |
Suggested the discontinuation of Coflin Lintus®. | 3 (8.3) | 33 (91.7) |